Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells

Cardiovasc Res. 1993 Jul;27(7):1233-6. doi: 10.1093/cvr/27.7.1233.

Abstract

Objectives: The underlying pathophysiological mechanism leading to raised blood pressure after treatment with erythropoietin is a point of much discussion. Direct vasopressor effects of erythropoietin have been shown recently. The aim was to determine whether erythropoietin effects cytosolic free calcium concentration ([Ca2+]i in vascular smooth muscle cells.

Methods: The effect of erythropoietin on ([Ca2+]i was measured with the fluorescent dye fura2 in cultured vascular smooth muscle cells from Wistar Kyoto rats.

Results: Mean resting [Ca2+]i was 90.8(SEM 5.6) nM (n = 32). Addition of erythropoietin at concentrations of 100 U.ml-1 and 250 U.ml-1 increased [Ca2+]i to 112.3(5.0) nM (n = 23, p < 0.05) and 128.4(4.0) nM (n = 10, p < 0.01), respectively. Preincubation with erythropoietin caused a dose dependent increase in angiotensin II induced changes of [Ca2+]i in vascular smooth muscle cells.

Conclusions: One mechanism of erythropoietin induced hypertension may be an increase in [Ca2+]i in vascular smooth muscle cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cells, Cultured
  • Cytosol / metabolism*
  • Dose-Response Relationship, Drug
  • Erythropoietin / pharmacology*
  • Male
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Rats
  • Rats, Inbred WKY

Substances

  • Erythropoietin
  • Calcium